|
| Source | SC-AdSCs | BFPSCs | Ref |
|
| Volume of harvested adipose tissue | Human | 37 ml | 0.8 ml | [12] |
| Number of cells isolated form adipose tissue | Human | 1.15 × 105 (cells/ml) | 1.1 × 105 (cells/ml) | [12] |
| Human | 513 × 103 (cells/gram) after 1 week of culture | 253 × 103 (cells/gram) after 1 week of culture | [9] |
| Number of cells | Human | 1.3 × 106 after 21 days, starting from 6 × 104 AdSCs | 5.9 × 105 after 21 days, starting from 6 × 104 AdSCs | [12] |
| Doubling time (h) | Human | 73.5 | 126.5 | [12] |
| Swine | 82.9 | 72.5 | [13] |
| Morphology and size | Human | Fibroblast-like shape | Slightly smaller and rounder compared with SC-AdSCs | [12] |
| Human | Fibroblast-like shape | Fibroblast-like shape | [13] |
| Swine | Spindle-shaped morphology after seeding and fibroblast-like morphology after 7 days of culture | Similar to SC-AdSCs | [9] |
| Clonogenicity expressed as the percentage of cells able to produce CFU-F from passages 1 to 4 | Human | — | 9.2% | [12] |
| Human | 10.1% | 8.9% | [13] |
| Expression of specific MSC markers | Human | CD73+, CD90+, and CD105+; CD14−, CD31−, and CD34− | Similar to SC-AdSCs | [12] |
| Swine | (i) CD146+CD29+ was observed in initial passaged BFPSCs, but not SC-AdSCs | [9] |
| (ii) CD34 was much higher in BFPSCs than in SC-AdSCs |
| (iii) CD105 was not observed in BFPSCs at first but increased by passaging the cells |
| Collagen level increase by osteodifferentiated cells after 14 days of culture | Human | 137.5% | 74.5% | [12] |
| Swine | 87% | 254% | [13] |
| ALP activity increase by osteodifferentiated cells after 14 days of culture | Human | 553% | 419% | [12] |
| Swine | 126% | 201% | [13] |
| Adipogenic differentiation capacity after 14 days of culture | Human | No difference | No difference | [12] |
| GAGs content increase in chondrogenic-differentiated porcine cells after 21 days | Swine | 184% | 149% | [13] |
|
